CareCloud, Inc. (CCLD) AI Stock Analysis

CareCloud, Inc., headquartered in Somerset, New Jersey, provides cloud-based solutions and business services tailored for healthcare providers and hospitals across the United States. Operating through its Healthcare IT and Practice Management segments, the company offers a Software-as-a-Service platform featuring revenue cycle management, practice management, electronic health records, business intelligence, telehealth, and patient experience tools. Originally founded in 1999 as MTBC, Inc. and rebranded in March 2021, CareCloud supports clinicians, physicians, and medical practices with software and operational support designed to improve clinical workflows, billing efficiency, and administrative operations.

CareCloud produced $120.5M in revenue in FY2025, up 8.7% from $110.8M in FY2024, supported by a 46.5% gross margin and a 9.5% operating margin. Net income rose to $10.8M from $7.9M in FY2024, recovering from a net loss of $48.7M in FY2023. Over the five years from FY2020 to FY2025, revenue compound annual growth was 2.8%. For the trailing twelve months, revenue stood at $128.6M with a profit margin of 6.2% and EPS of $0.06. In the latest quarter ended June 30, 2026, revenue increased 16.4% year-over-year, while quarterly earnings contracted 88.3%.

As of June 30, 2026, CareCloud held $13.4M in cash and short-term investments against total debt of $54.0M, resulting in net debt of $40.6M. Total assets were $93.8M against shareholders' equity of $17.4M, with a current ratio of 1.02 and a debt-to-equity ratio of 3.10. In FY2025, the business generated $28.6M in operating cash flow and $20.5M in free cash flow. Capital expenditures totaled $8.0M, share buybacks were $24,000, and dividends paid were $6.3M. Outstanding shares grew 185.2% over five years.

CCLD trades at a trailing price-to-earnings ratio of 30.8x compared to the median of 24.6x for its US-listed Healthcare peers. Its forward P/E is 4.0x versus the peer median of 17.3x, while its enterprise value to EBITDA sits at 4.7x against the peer median of 12.0x. CareCloud carries a price-to-sales multiple of 0.6x and a price-to-book ratio of 5.0x. Over the past year, the stock declined 40.3%, trailing the S&P 500 (SPY) return of 16.8%, and its five-year return is -75.3% versus 83.0% for the index.

Wall Street coverage consists of 1 Strong Buy and 1 Buy rating, with no Hold or Sell recommendations. The mean price target is $7.33, which is 296.4% above the last closing price of $1.85. For the fiscal year ending December 31, 2026, analysts forecast revenue of $130.3M and EPS of $0.36. For the next fiscal year, two analysts project revenue of $142.9M and EPS of $0.30. CareCloud beat earnings per share estimates in 2 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of CareCloud, Inc. (CCLD). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CCLD income statement, CCLD balance sheet, CCLD key metrics, CCLD analyst forecast, CCLD chart. See the CCLD stock overview for the latest quote and news.